Clinical characteristics and phenotypical and molecular analysis in a series of patients with refractory sprue. Preliminary results

2000 ◽  
Vol 118 (4) ◽  
pp. A368 ◽  
Author(s):  
Eduardo Maurino ◽  
Alejandra Cherniasky ◽  
Sonia I Niveloni ◽  
Nahuel Fittipaldi ◽  
Ana Cabanne ◽  
...  
Author(s):  
Yuwadee Somsap ◽  
Patcharaporn Boonroumkaew ◽  
Attawit Somsap ◽  
Rutchanee Rodpai ◽  
Lakkhana Sadaow ◽  
...  

A rare ocular dirofilariasis case along with the clinical characteristics, treatment, and outcome is reported. A whitish roundworm (10.6 cm long and 0.5 mm width) emerged from the pterygium, a triangular tissue growth on the cornea of the eye, of a male patient. The worm had a rounded anterior part, mouth without lips, smooth cuticular surface, and short rounded posterior tail with spicules: these features suggested that it was a male Dirofilaria sp. Molecular identification confirmed that the worm belonged to Dirofilaria immitis. This is the first molecular confirmation that D. immitis is a causative agent of ocular dirofilariasis in Thailand: dirofilariasis is a newly emerging zoonotic disease. Physicians should be alert to zoonotic filarial worms and knowledgeable about treatment of this disease.


Blood ◽  
2016 ◽  
Vol 128 (22) ◽  
pp. 2503-2503
Author(s):  
Ali Hakan Kaya ◽  
Emre Tekgunduz ◽  
Filiz Bekdemir ◽  
Hikmetullah Batgi ◽  
Tugcenur Yigenoglu ◽  
...  

Abstract Introduction : Febrile neutropenia (FN) is an important cause of mortality in hematology practice. Prompt recognition and treatment of FN is crucial to prevent development of sepsis and subsequent mortality. The duration of empirical antibiotherapy in hemodynamically stabile, afebrile, culture negative patients without an infectious focus is a controversial issue. Recently published guidelines encourage the use of early cessation of empirical antibiotherapy in these patients. Here we report our preliminary experience of early discontinuance of empirical antibiotherapy in febrile neutropenic patients who were treated with a risk-adapted strategy. Methods: All consecutive patients who were treated during June 2014-April 2016 period and presented with FN were included. Demographic and clinical data of patient cohort was prospectively collected within the context of institutional FN registry and analyzed retrospectively. Previously established standard criteria are used to diagnose FN episodes. MASCC score defined the risk category of patients. A new FN episode was considered when FN re-occurred in a patient who remained afebrile for at least 72 hours after discontinuation of antibiotics. All patients were treated within the framework of a written, institutional FN guideline, which is in line with EGIL-4 (European Conference on Infections in Leukemia) recommendations. Empirical antibiotherapy was stopped in patients, who were hemodynamically stabile, had no infectious focus, had negative culture results, received broad-spectrum empiric antibiotherapy for 3 days and were afebrile for at least 2 days. Results: The study included a total of 137 patients (87 males-50 females). Median age of patients was 49 (16-87). All patients were in high-risk group according to MASSC criteria. Demographic and clinical features of the study cohort are summarized in Table-1. During the study period 249 FN episodes were evaluated. Empirical antibiotherapy was discontinued in 47 (18,9%) FN episodes in 44 (32,1%) patients. Following cessation of empirical antibiotherapy, 11 (23,4%) new FN episodes developed and no patient infection-related deaths in the following 100 days. Discussion: Our preliminary results indicate that cessation of empirical antibiotherapy in a strictly defined patient population with FN seems to be feasible. We were able to stop antibiotherapy in 18,9% of patients and 76,6% of them did not experience a new FN episode. This strategy is cost-effective and seems to be quite safe, as we did not observed any infection-related deaths in the first 100 days following discontinuation of antibiotherapy. These patients were also protected from possible side effects of unnecessary antibiotics. Future studies will define the role of this provocative approach and may change the way we treat febrile neutropenic patients. Table Demographic and clinical characteristics of patients Table. Demographic and clinical characteristics of patients Disclosures Demirkan: Amgen: Consultancy.


2010 ◽  
Vol 28 (15_suppl) ◽  
pp. 1510-1510
Author(s):  
M. M. Patnaik ◽  
S. Khambatta ◽  
S. I. Robinson ◽  
R. L. Richardson ◽  
M. P. Goetz

2010 ◽  
Vol 72 (5) ◽  
pp. 454-459 ◽  
Author(s):  
Z.-Y. Zhang ◽  
X.-D. Zhao ◽  
L.-P. Jiang ◽  
E.-M. Liu ◽  
M. Wang ◽  
...  

2013 ◽  
Vol 39 (2) ◽  
pp. 181-189 ◽  
Author(s):  
Vinícius Buaes Dal'Maso ◽  
Lucas Mallmann ◽  
Marina Siebert ◽  
Laura Simon ◽  
Maria Luiza Saraiva-Pereira ◽  
...  

OBJECTIVE: To evaluate the diagnostic contribution of molecular analysis of the cystic fibrosis transmembrane conductance regulator (CFTR) gene in patients suspected of having mild or atypical cystic fibrosis (CF). METHODS: This was a cross-sectional study involving adolescents and adults aged ≥ 14 years. Volunteers underwent clinical, laboratory, and radiological evaluation, as well as spirometry, sputum microbiology, liver ultrasound, sweat tests, and molecular analysis of the CFTR gene. We then divided the patients into three groups by the number of mutations identified (none, one, and two or more) and compared those groups in terms of their characteristics. RESULTS: We evaluated 37 patients with phenotypic findings of CF, with or without sweat test confirmation. The mean age of the patients was 32.5 ± 13.6 years, and females predominated (75.7%). The molecular analysis contributed to the definitive diagnosis of CF in 3 patients (8.1%), all of whom had at least two mutations. There were 7 patients (18.9%) with only one mutation and 26 patients (70.3%) with no mutations. None of the clinical characteristics evaluated was found to be associated with the genetic diagnosis. The most common mutation was p.F508del, which was found in 5 patients. The combination of p.V232D and p.F508del was found in 2 patients. Other mutations identified were p.A559T, p.D1152H, p.T1057A, p.I148T, p.V754M, p.P1290P, p.R1066H, and p.T351S. CONCLUSIONS: The molecular analysis of the CFTR gene coding region showed a limited contribution to the diagnostic investigation of patients suspected of having mild or atypical CF. In addition, there were no associations between the clinical characteristics and the genetic diagnosis.


2008 ◽  
Vol 7 ◽  
pp. S12-S13
Author(s):  
R. Tomaiuolo ◽  
G. Cardillo ◽  
A. Elce ◽  
C. Bellia ◽  
V. Raia ◽  
...  

2011 ◽  
Vol 22 (5) ◽  
pp. 482-487 ◽  
Author(s):  
Zhi-Yong Zhang ◽  
Xiao-Dong Zhao ◽  
Li-Ping Jiang ◽  
En-Mei Liu ◽  
Yu-Xia Cui ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document